Molecular imaging insights into neurodegeneration: Focus on tau PET radiotracers

Journal of Nuclear Medicine

Volumn 55, Issue 6, 2014, Pages 871-874

  Shah, Maliha ^a   Catafau, Ana M ^a  

^a Piramal Enterprises Limited   (India)

Author keywords

Alzheimer's; Neurodegeneration; PET; Radiotracer; Tau

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN; TRACER; TUBULIN;

ALZHEIMER DISEASE; BASAL GANGLION; BRAIN NERVE CELL; CELL TRANSPORT; CELLULAR DISTRIBUTION; DISEASE SEVERITY; HIPPOCAMPUS; HUMAN; MICROTUBULE; MOLECULAR IMAGING; NEOCORTEX; NERVE DEGENERATION; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TEMPORAL CORTEX; DEGENERATIVE DISEASE; DRUG DEVELOPMENT; METABOLISM; PROCEDURES; SCINTISCANNING;

DRUG DISCOVERY; HUMANS; NEURODEGENERATIVE DISEASES; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; TAU PROTEINS;

EID: 84903120463     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.136069     Document Type: Review

References (21)

1. Spillantini MG, Goedert M. Tau pathology and neurodegeneration. Lancet Neurol. 2013;12:609-622.
2. Ittner LM, Gotz J. Amyloid-beta and tau: a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci. 2011;12:65-72.
3. Rohan Z, Matej R. Current concepts in the classification and diagnosis of frontotemporal lobar degenerations: a practical approach. Arch Pathol Lab Med. 2014;138:132-138.
4. Riedl L, Mackenzie IR, Forstl H, Kurz A, Diehl-Schmid J. Frontotemporal lobar degeneration: current perspectives. Neuropsychiatr Dis Treat. 2014;10:297-310.
5. Mathis CA, Klunk WE. Imaging tau deposits in vivo: progress in viewing more of the proteopathy picture. Neuron. 2013;79:1035-1037.
6. Villemagne VL, Furumoto S, Fodero-Tavoletti M, et al. The challenges of tau imaging. Future Neurol. 2012;7:409-421.
7. Smid LM, Kepe V, Vinters HV, et al. Postmortem 3-D brain hemisphere cortical tau and amyloid-beta pathology mapping and quantification as a validation method of neuropathology imaging. Journal of Alzheimers Dis. 2013;36:261-274.
8. Shao X, Carpenter GM, Desmond TJ, et al. Evaluation of [ 11C]N-methyl lansoprazole as a radiopharmaceutical for PET imaging of tau neurofibrillary tangles. ACS Med Chem Lett. 2012;3: 936-941.
9. Maruyama M, Shimada H, Suhara T, et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron. 2013;79:1094-1108.
10. 11C]PBB3 - a new PET ligand that identifies tau pathology in the brains of patients with AD. Nat Rev Neurol. 2013;9:599.
11. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease. Brain. 2011;134:1089-1100.
12. Tago T, Furumoto S, Okamura N, et al. Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging. J Labelled Comp Radiopharm. 2014;57:18-24.
13. 18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology. Eur J Nucl Med Mol Imaging. 2013;40:125-132.
14. Villemagne VL, Furumoto S, Fodero-Tavoletti MT, et al. In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2014;41:816-826.
15. 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease. J Nucl Med. 2013;54:1420-1427.
16. 18F-THK5105 PET. Brain. March 27, 2014 [Epub ahead of print].
17. Zhang W, Arteaga J, Cashion DK, et al. A highly selective and specific PET tracer for imaging of tau pathologies. J Alzheimers Dis. 2012;31:601-612.
18. 18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. Alzheimers Dement. 2013;9:666-676.
19. Chien DT, Szardenings AK, Bahri S, et al. Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808. J Alzheimers Dis. 2014;38:171-184.
20. Chien DT, Bahri S, Szardenings AK, et al. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis. JAD. 2013;34:457-468.
21. Josephs KA, Whitwell JL, Weigand SD, et al. TDP-43 is a key player in the clinical features associated with Alzheimer's disease. Acta Neuropathol. March 23, 2014 [Epub ahead of print].